Clinical Trial Detail

NCT ID NCT03484520
Title A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications

acute myeloid leukemia

Therapies

Dinaciclib + Venetoclax

Age Groups: senior adult

No variant requirements are available.